Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2003;30(3):236-9.

Percutaneous closure of window-type patent ductus arteriosus: using the CardioSEAL and STARFlex devices

Affiliations
Case Reports

Percutaneous closure of window-type patent ductus arteriosus: using the CardioSEAL and STARFlex devices

Jacek Bialkowski et al. Tex Heart Inst J. 2003.

Abstract

Transcatheter closure of patent ductus arteriosus is routinely performed using various devices. After the withdrawal of the Rashkind umbrella device from the market, the wide window-type patent ductus arteriosus has been difficult to close percutaneously. Two patients with this condition are presented: a 17-year-old man and a 62-year-old woman with short (4.5- and 5.2-mm-diameter, respectively) ductus. We successfully implanted a 17-mm CardioSEAL device in the 1st patient and a 23-mm STARFlex in the 2nd, with no residual shunt at follow-up (22 and 8 months, respectively). Although these devices (which follow the general design of the Rashkind umbrella) are usually applied to atrial septal defect closure, we believe that CardioSEAL and STARFlex implants could be the treatment of choice in percutaneous treatment.of window-type patent ductus arteriosus.

PubMed Disclaimer

Figures

None
Fig. 1 Patient 2: Aortogram in lateral view shows the window-type patent ductus arterious (arrow) A) before and B) after implantation of a STARFle® device, which is still attached to the delivery system.
None
Fig. 2 Patient 1: Aortogram in lateral view shows the window-type patent ductus arterious (arrow) A) before and B) after complete closure of the PDA with a CardioSEAL® device.

References

    1. Gersony WM, Apfel HD. Patent ductus arteriosus and other aortopulmonary anomalies. In: Moller JH, Hoffman JI, editors. Pediatric cardiovascular medicine. New York: Churchill Livingstone; 2000. p. 323–34.
    1. Kaulitz R, Paul T, Hausdorf G. Extending the limits of transcatheter closure of atrial septal defects with the double umbrella device (CardioSEAL). Heart 1998;80:54–9. - PMC - PubMed
    1. Hung J, Landzberg MJ, Jenkins KJ, King ME, Lock JE, Palacios JF, Lang P. Closure of patent foramen ovale for parodoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000;35:1311–6. - PubMed
    1. Krichenko A, Benson LN, Burrows P, Moes CA, McLaughin P, Freedom RM. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol 1989;63:877–80. - PubMed
    1. Cambier PA, Kirby WC, Worham DC, Moore JW. Percutaneous closure of the small (less than 2.5 mm) patent ductus arteriosus using coil embolization. Am J Cardiol 1992;69:815–6. - PubMed

Publication types